Repurposing Alzheimer’s and ovarian cancer drugs as sonosensitizers for glioblastoma via a positive-unlabeled learning and 3D bioprinting-based new approach methodology (NAM)
Rudrajit Majumder, Priyankan Datta, Sreejesh Moolayadukkam, Ishwar K Puri · 2026
Read Repurposing Alzheimer’s and ovarian cancer drugs as sonosensitizers for glioblastoma via a positive-unlabeled learning and 3D bioprinting-based new approach methodology (NAM) by Rudrajit Majumder, Priyankan Datta, Sreejesh Moolayadukkam, Ishwar K Puri (2026) in the Tower of Babel, a free online library of public-domain works preserved in clean, searchable text. No sign-up. The full text is served as a plain-text file at a predictable URL, where text is present: https://antarctic-labs.com/tower-of-babel/plos-pone-0354981.txt.
Description
Rudrajit Majumder and co-authors hunted for existing drugs that ultrasound could turn into weapons against glioblastoma. This brain tumour resists treatment partly because the blood-brain barrier blocks medicines. Sound-activated therapy can strike deep tissue without surgery, but proven activator drugs are scarce. Their 2026 pipeline pairs machine learning with printed tumour models.
A classifier trained without reliable negative examples scanned drug libraries for ultrasound-responsive candidates, including drugs first developed for Alzheimer's disease and ovarian cancer. Promising picks were then tested in three-dimensional printed tumour balls that mimic the real tumour's oxygen-starved core. Majumder and colleagues present the combined screen as a faster route to repurposed brain tumour treatments.
Catalog record
| CREATOR | Rudrajit Majumder, Priyankan Datta, Sreejesh Moolayadukkam, Ishwar K Puri |
|---|---|
| YEAR | 2026 |
| COLLECTION | PAPERS |
| FORMAT | TXT |
| FILE SIZE | 50387 |
| LICENSE | CC_BY |
| RIGHTS | CC BY |
| SOURCE | PLOS |